02/04/2025
3:02 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:02 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
3:50 PM | Panbela Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/19/2024
5:40 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:00 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:01 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:02 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:03 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:04 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/18/2024
4:05 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
Get the Latest News and Ratings for PBLA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/18/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:00 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:15 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:03 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:06 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:09 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
11/15/2024
5:12 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
6:40 PM | Nant Capital, LLC (Filed by)
Panbela Therapeutics (Subject)
| Form SC 13D | |
10/29/2024
6:38 PM | Nant Capital, LLC (Reporting)
Panbela Therapeutics (Issuer)
SOON-SHIONG PATRICK (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:24 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:25 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:26 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/29/2024
8:27 AM | Panbela Therapeutics (Filer)
| Form 424B3 | |
10/28/2024
4:16 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:26 PM | Horvath Susan (Reporting)
Panbela Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:34 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:25 PM | Panbela Therapeutics (Filer)
| Form S-1/A | |
08/13/2024
7:39 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:40 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:42 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:43 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:45 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:46 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
7:47 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024
4:30 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
$5,000 DOGE check? (Ad) Elon Musk's DOGE agenda just took a very surprising turn...
Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers.
The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail. Everything you need to know is right here. |
07/30/2024
3:59 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
3:46 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
6:00 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:21 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:22 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:24 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:27 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
7:29 PM | Panbela Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
3:16 PM | Panbela Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
3:35 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
8:09 AM | Nasdaq Stock Market LLC (Filed by)
Panbela Therapeutics (Subject)
| Form 25-NSE | |
04/22/2024
7:02 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
3:31 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
04/17/2024
7:36 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
3:17 PM | Panbela Therapeutics (Filer)
| Form DEF 14A | |
04/02/2024
11:15 PM | Panbela Therapeutics (Filer)
| Form EFFECT | |
03/29/2024
4:08 PM | Panbela Therapeutics (Filer)
| Form POS AM | |
03/29/2024
4:24 PM | Panbela Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/26/2024
3:15 PM | Panbela Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:12 PM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
5:01 AM | Panbela Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
